<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00515047</url>
  </required_header>
  <id_info>
    <org_study_id>DAIT ADVN GENE 04</org_study_id>
    <secondary_id>HHSN266200400033</secondary_id>
    <nct_id>NCT00515047</nct_id>
  </id_info>
  <brief_title>Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis</brief_title>
  <acronym>Genetics</acronym>
  <official_title>Genetics of Atopic Dermatitis - Eczema Herpeticum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Allergy and Infectious Diseases (NIAID)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      People with atopic dermatitis (AD), or eczema, are susceptible to skin infections and
      inflammations. Some individuals with AD develop a condition known as eczema herpeticum (EH)
      following exposure to the herpes simplex virus (HSV). The purpose of this study is to
      identify the genetic determinants that lead people with AD to develop EH and similar
      conditions caused by other viruses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AD is a chronic inflammatory skin disorder characterized by recurrent viral skin infections.
      However, people with AD do not all develop the same infections. For example, some people with
      AD who receive the smallpox vaccine develop a life-threatening condition known as eczema
      vaccinatum (EV). This study focuses on individuals with AD who also have a history of eczema
      herpeticum (ADEH+), a condition similar to EV. It is unlikely that the differences in the
      development of skin infections are due to differences in viral exposure, and instead due to
      differences in each individual's response to viruses. The purpose of this study is to
      determine the genetic pathways which are responsible for the development of viral skin
      infections in people with AD.

      Participants in this study will also be enrolled in the ADVN Biomarker Registry Study. There
      will be only one clinical visit for this study at which blood and/or skin samples may be
      collected. The samples will then have high-throughput genotyping to define genetic markers in
      individuals susceptible to viral infections.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of variants/haplotypes in EH-associated genes and characterization of frequencies of variants in priority candidate genes for EH</measure>
    <time_frame>Throughout Study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identification and prioritization of novel genes induced in response to viral infection (HSV/Vaccinia and MCV) in AD participants and relevant control groups</measure>
    <time_frame>Throughout Study</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">900</enrollment>
  <condition>Atopic Dermatitis</condition>
  <arm_group>
    <arm_group_label>Eczema Herpeticum (EH)</arm_group_label>
    <description>Participants with AD who currently have or have had EH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-EH</arm_group_label>
    <description>Participants with AD who do not have and have never had EH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Healthy participants without a history of AD</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Skin scrapings and blood collection may occur
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        African-American, Caucasian, and Non-Hispanic people ages 8 months to 80 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Enrollment in ADVN Biomarker Registry Study

          -  Non-Hispanic and only African American or only Caucasian race

          -  Parent or guardian willing to provide informed consent, if necessary

        Exclusion Criteria:

          -  History of any systemic illness, excluding AD

          -  Participation of a first degree relative already enrolled in the genotyping study
             unless the subject in question fulfills the diagnostic criteria for ADEH+. More
             information on this criterion can be found in the protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Months</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Beck, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kathleen Barnes, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Allergy and Asthma Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California at San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Sciences University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nationaljewish.org/adrn/index/</url>
    <description>Click here for more information about the Atopic Dermatitis and Vaccinia Network</description>
  </link>
  <reference>
    <citation>Baker BS. The role of microorganisms in atopic dermatitis. Clin Exp Immunol. 2006 Apr;144(1):1-9. Review.</citation>
    <PMID>16542358</PMID>
  </reference>
  <reference>
    <citation>Kim BE, Leung DY, Streib JE, Kisich K, Boguniewicz M, Hamid QA, Howell MD. Macrophage inflammatory protein 3alpha deficiency in atopic dermatitis skin and role in innate immune response to vaccinia virus. J Allergy Clin Immunol. 2007 Feb;119(2):457-63. Epub 2006 Dec 4. Erratum in: J Allergy Clin Immunol. 2008 Nov;122(5):1007.. Kisich, Kevin [added].</citation>
    <PMID>17141855</PMID>
  </reference>
  <reference>
    <citation>Porter CD, Muhlemann MF, Cream JJ, Archard LC. Molluscum contagiosum: characterization of viral DNA and clinical features. Epidemiol Infect. 1987 Oct;99(2):563-6.</citation>
    <PMID>2824227</PMID>
  </reference>
  <reference>
    <citation>Umene K, Yoshida M, Sakaoka H. Comparison of the association with eczema herpeticum in the two predominant genotypes of herpes simplex virus type 1. J Med Virol. 1996 Aug;49(4):329-32.</citation>
    <PMID>8877767</PMID>
  </reference>
  <results_reference>
    <citation>Gao PS, Leung DY, Rafaels NM, Boguniewicz M, Hand T, Gao L, Hata TR, Schneider LC, Hanifin JM, Beaty TH, Beck LA, Weinberg A, Barnes KC. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol. 2012 Mar;132(3 Pt 1):650-7. doi: 10.1038/jid.2011.374. Epub 2011 Nov 24.</citation>
    <PMID>22113474</PMID>
  </results_reference>
  <results_reference>
    <citation>Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol. 2010 Jun;125(6):1403-1407.e4. doi: 10.1016/j.jaci.2010.03.016. Epub 2010 May 13.</citation>
    <PMID>20466416</PMID>
  </results_reference>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2007</study_first_submitted>
  <study_first_submitted_qc>August 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2007</study_first_posted>
  <last_update_submitted>April 1, 2014</last_update_submitted>
  <last_update_submitted_qc>April 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atopic Dermatitis</keyword>
  <keyword>Eczema</keyword>
  <keyword>Eczema Herpeticum</keyword>
  <keyword>Molluscum Contagiousum</keyword>
  <keyword>Herpes Simplex</keyword>
  <keyword>Vaccinia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Kaposi Varicelliform Eruption</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

